MedPath

Dietary Fat and Endothelial Function in Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Dietary Supplement: EVOO supplementation
Dietary Supplement: Butter supplementation
Registration Number
NCT04812782
Lead Sponsor
University Magna Graecia
Brief Summary

The purpose of this study is to evaluate the effects of the add-on of extra vergin olive oil or butter to a high glycemic index meal on endothelial function in subjects with type 1 Diabetes and healthy subjects.

Detailed Description

Impaired endothelial function is an early manifestation of atherosclerosis and predictor of incident cardiovascular events. Diabetes affects arterial vasodilation by reducing the bioavailability of NO and more in general affecting the balance between the atheroprotective and atherothrombotic properties of the endothelium. A consistent number of studies has so far documented that Mediterranean-style diet associates with reduced risk of cardiovascular diseases and diabetes. Intake of extra virgin olive oil (EVOO), that is a common but not necessary ingredient of the Mediterranean diet, seems to further enhance the beneficial cardiovascular effect and reduce the incidence of diabetes. We have designed the present study to test whether EVOO supplementation acutely influences endothelial function in T1DM. EVOO supplementation wil be compared to butter supplementation in the context of a high glycemic index (GI) meal that is known to increase PP glycemic burden.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • age ≥ 18 years,
  • diagnosis of type 1 diabetes since at least 1 year,
  • HbA1c <8.5% (69 mmol/mol),
  • stable insulin therapy for at least 3 months before the enrolment into the study
Exclusion Criteria
  • pregnancy, celiac disease, history of cardiovascular diseases, hypertension, hyperlipidemia, retinopathy, nephropathy, neuropathy, and ongoing treatment with vasoactive drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
EVOO-ButterEVOO supplementationAll patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with EVOO and the second with butter.
Butter-EVOOEVOO supplementationAll patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with Butter and the second with EVOO
EVOO-ButterButter supplementationAll patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with EVOO and the second with butter.
Butter-EVOOButter supplementationAll patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with Butter and the second with EVOO
Primary Outcome Measures
NameTimeMethod
Change of Endothelial function from pre meal to post meal periodbefore meal, 1 hour, 3 hour, 5 hour after meal

Flow mediated dilation technique by ultrasound

Secondary Outcome Measures
NameTimeMethod
Serum glucosebefore meal, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour after meal

glucose-hexokinase method

Gastric emptying ratebefore meal, 15, 90, 120, 180, 240, 300 minutes after meal

Ultrasound antrum measurement

Trial Locations

Locations (1)

University Magna Graecia

🇮🇹

Catanzaro, Italy

© Copyright 2025. All Rights Reserved by MedPath